Should investors buy into GlaxoSmithKline's turnaround story?
News & Analysis: GlaxoSmithKline
GSK earnings call for the period ending March 31, 2019.
These three biotech stocks are worth buying this month.
These dividend stocks offer better yields and growth potential than the beverage giant.
Eli Lilly and GlaxoSmithKline are both pharma royalty. Which stock is the better buy right now?
Find out which iconic pharmaceutical giant is the better stock pick at the moment.
GSK earnings call for the period ending December 31, 2018.
You use their products. Should you own their stock, too?
Pfizer and GlaxoSmithKline join forces with their consumer healthcare businesses, creating plenty of synergies.
Looking for big yield? ExxonMobil has it, but these three stocks should also be on your radar.